There were 1,527 press releases posted in the last 24 hours and 442,746 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Tiziana Life Sciences Expands Phase 2 Clinical Trial of Intranasal Foralumab with Commencement of First Patient Dosing at Weill Cornell Multiple Sclerosis Center

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image